Artificial intelligence (AI) might be able to help doctors make glaucoma screening widely available, a new study says.

The findings could enable earlier detection and treatment for people affected by the serious eye condition. A research team ...

A licensing agreement between SERI and Eyexora Global has launched Y.ora Vision, a new ophthalmic medical device company.

This case, Singh notes, has profoundly influenced his philosophy of glaucoma management: balancing surgical risk with the ...

Proactive strategies in glaucoma care, including minimally invasive glaucoma surgery (MIGS) and physician decision-making, ...

The vision of a content creator from Minnesota has been gradually deteriorating since she was 6 years old. At 27, she's learning to live differently and independently.

While artificial intelligence (AI)-powered screening has been validated for diabetic retinopathy, applying the technology to glaucoma has proved more challenging because glaucoma is not one disease. A ...

New company to develop novel surgical device for mild-to-severe glaucoma, improving safety, efficiency, and durability SINGAPORE, October 16, 2025--(BUSINESS WIRE)--Y.ora Vision, Inc., a new ...

Legendary investor Vinod Khosla has weighed in on OpenAI's new Sora video-generation app. Since its release this week, some critics have branded the videos coming from Sora as "AI slop." Khosla, one ...

Background/Aims The neuroprotective effect of nicotinamide (NAM) supplementation has been demonstrated in both animal models ...

TORONTO and HAIFA, Israel, Oct. 08, 2025 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX) (OTCQB: NRXBF) (FSE: J90) (“NurExone ” or the “Company ”) a ...